Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Cerebrospinal fluid interleukin-6 in central nervous system inflammatory diseases.
Hypertrophic pachymeningitis accompanying neuromyelitis optica spectrum disorder: A case report.
Importance of Apolipoprotein A-I in Multiple Sclerosis.
Microglia and astrocyte activation in the frontal cortex of rats with experimental autoimmune encephalomyelitis.
Phosphodiesterase-5 Inhibitors: Action on the Signaling Pathways of Neuroinflammation, Neurodegeneration, and Cognition.
Numerical status of CD4(+)CD25(+)FoxP3(+) and CD8(+)CD28(-) regulatory T cells in multiple sclerosis.
Alterations in tight junction protein and IgG permeability accompany leukocyte extravasation across the choroid plexus during neuroinflammation.
Drug repurposing: a systematic approach to evaluate candidate oral neuroprotective interventions for secondary progressive multiple sclerosis.
Adult neurogenesis and neurodegenerative diseases: A systems biology perspective.
Neuromyelitis optica (NMO IgG+) and genetic susceptibility, potential ethnic influences.
Neurological disorders and celiac disease.
SURF1 deficiency causes demyelinating Charcot-Marie-Tooth disease.
Cortical plasticity predicts recovery from relapse in multiple sclerosis.
Development of a patient-centred conceptual framework of health-related quality of life in neuromyelitis optica: a qualitative study.
Angiopoietin-1 and C16 Peptide Attenuate Vascular and Inflammatory Responses in Experimental Allergic Encephalomyelitis.
A study on the direct and indirect costs of multiple sclerosis based on expanded disability status scale score in khuzestan, iran.
Chemokine biomarkers in central nervous system tissue and cerebrospinal fluid in the Theiler's virus model mirror those in multiple sclerosis.
Impact of MS genetic loci on familial aggregation, clinical phenotype, and disease prediction.
[The role and place of high-dose immunosuppressive therapy and autologous transplantation of hematopoietic stem cells for autoimmune diseases].
Does the preclinical evidence for functional remyelination following engraftment into the injured spinal cord support progression to clinical trials?
Mechanisms and therapeutic implications of the placebo effect in neurological and psychiatric conditions.
Analysis of the host transcriptome from demyelinating spinal cord of murine coronavirus-infected mice.
Antigen-stimulated rosette formation by T lymphocytes in experimental allergic encephalomyelitis.
Effect of microtubule disruption on neuronal spread and replication of demyelinating and non demyelinating strains of mouse hepatitis virus in vitro.
Aminopropyl carbazole analogues as potent enhancers of neurogenesis.
Pages
« first
‹ previous
…
690
691
692
693
694
695
696
697
698
…
next ›
last »